We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges"
News

PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges"

PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges"
News

PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges"

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges""

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

PharmaFrontiers Corp. has announced that David B. McWilliams, chief executive officer of PharmaFrontiers, will make a presentation entitled, "Embracing the Realities of Stem Cell Commercialization," at the upcoming Marcus Evans conference.

The presentation will be given on June 9, 2006 at the Hyatt Regency Hotel in San Francisco at 3:30 pm pacific time.

A copy of the presentation will be posted to the Company's Web site following Mr. McWilliams' talk.

In his presentation, Mr. McWilliams will discuss PharmaFrontiers' proprietary stem cell technology, which uses adult pluripotent stem cells derived from patients' own circulating blood.

In addition, he will discuss the key factors for success in the commercialization of stem cell therapies and the ways in which PharmaFrontiers is able to address the challenges facing the available technologies.

Advertisement